BioPharma ABVC Gains 280 Support Holds at 104 20260519
Mexco MXC Stock Today Rallies 143 Resistance at 1007 20260515
Theriva Biologics TOVX Stock Jumps 137 Approaching 030 20260518
Ranpak Holdings PACK Reports Strong Q1 2026 Revenue NA EPS Beats
SK Hynix Shatters Profit Records as AI Chip Demand Fuels Memory Boom
Global Leaders Watch TrumpXi Summit for Trade Signals
Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday
USIran Standoff Deepens as Trump Rejects Peace Counteroffer Threatening Global Energy Supplies
MegaIPOs Could Signal Market Top as SpaceX and OpenAI Prep Record Floats
The Mandalorian and Grogu Posts Lowest Star Wars Opening for Disney with 82M Debut
NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline
DUK Q1 2026 Earnings EPS Surpasses Estimates as Duke Energy Delivers Steady Operations
MPLT Q1 2026 Earnings WiderthanExpected Loss Reflects Continued Development Spending
SKIN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 421
Power REIT PW Q2 2025 Earnings Reports Positive EPS Amid Limited Disclosure
Neonode Inc NEON Q1 2026 Earnings EPS Misses Estimates by Nearly 8
Art Technology Acquisition Corp ARTC Holds Near Key Levels with Minimal Price Movement
PS International Group PSIG Surges 183 as Stock Tests Key Resistance Level at 82
Ryanair Holdings RYAAY Edges Lower Consolidation Phase Near 6086 Amid Ongoing Sector Headwinds
Duluth Holdings DLTH Jumps 43 as Stock Tests Critical Resistance Zone
OFS Credit Company Inc OCCI Edges Higher Navigating Support and Resistance Levels
Trump Organization Tbilisi Project Raises ConflictofInterest Concerns Over Sanctioned Ties
ADAML Q1 2026 Earnings Significant EPS Beat as Preferred Stock Delivers Strong Performance
CVD Equipment Corporation CVV Surges Over 4 Key Levels to Watch
Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts
ADAM Q1 2026 Earnings Strong EPS Beat Drives Optimism
CCCC Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
GTIM Q1 2026 Earnings Modest Profitability Amid Operational Challenges
Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines
ePlus inc PLUS Q1 2026 Earnings EPS Surges 4075 Above Estimates Stock Rises
LW Q1 2026 Earnings EPS Surpasses Estimates Amid Resilient Demand